Fabino Enterprises Ltd

AI

Fabino Enterprises Ltd

₹ 20.3 4.96%
27 Apr 2026
About

Incorporated in 2011, Fabino Enterprises manufactures, markets, trades, and does packing of pharmaceutical and other wellness focused consumer products[1]

Key Points

Business Overview:[1][2]
a) FEL is an ISO 9001:2015 pharmaceutical company located near the Delhi NCR region. It offers a wide range of allopathic and herbal products.
b) Company markets pharmaceutical formulation for domestic market and sells through own distribution network and sales force under
their own brand name
c) It gets Ayurvedic formulations manufactured through Loan Licensing facilities, Packing, Labelling etc.
d) Company exports wellness and FMCG products like Coffee, Malt powder, Protein powder, Hair shampoo which it also markets

  • Market Cap ₹ 4.27 Cr.
  • Current Price ₹ 20.3
  • High / Low ₹ 27.0 / 13.0
  • Stock P/E
  • Book Value ₹ 18.7
  • Dividend Yield 0.00 %
  • ROCE -6.22 %
  • ROE -8.76 %
  • Face Value ₹ 10.0

Pros

  • Company has reduced debt.
  • Stock is trading at 1.09 times its book value
  • Company's working capital requirements have reduced from 174 days to 137 days

Cons

  • Company has low interest coverage ratio.
  • Company has a low return on equity of -1.44% over last 3 years.
  • Company has high debtors of 405 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
2.38 2.05 2.15 1.04 2.32 0.94 5.14 4.25 13.78 0.68 10.75
2.15 2.11 2.00 1.03 2.30 0.87 5.10 4.21 13.65 0.94 12.04
Operating Profit 0.23 -0.06 0.15 0.01 0.02 0.07 0.04 0.04 0.13 -0.26 -1.29
OPM % 9.66% -2.93% 6.98% 0.96% 0.86% 7.45% 0.78% 0.94% 0.94% -38.24% -12.00%
0.00 0.01 0.00 0.02 0.00 0.00 0.00 0.11 0.18 0.15 1.16
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.06 0.07 0.08 0.05
Depreciation 0.02 0.00 0.03 0.02 0.02 0.01 0.01 0.02 0.04 0.05 0.05
Profit before tax 0.21 -0.05 0.12 0.01 0.00 0.06 0.01 0.07 0.20 -0.24 -0.23
Tax % 0.00% 0.00% 16.67% 0.00% 33.33% 0.00% 28.57% 55.00% 0.00% -52.17%
0.21 -0.05 0.10 0.01 0.00 0.05 0.00 0.05 0.09 -0.25 -0.11
EPS in Rs 1.75 -0.42 0.48 0.05 0.00 0.24 0.00 0.24 0.43 -1.19 -0.52
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
2.76 7.52 3.06 4.19 3.36 6.01 18.01 11.42
2.44 7.20 2.99 4.09 3.33 5.90 17.84 12.96
Operating Profit 0.32 0.32 0.07 0.10 0.03 0.11 0.17 -1.54
OPM % 11.59% 4.26% 2.29% 2.39% 0.89% 1.83% 0.94% -13.49%
0.00 0.00 0.00 0.01 0.02 0.00 0.29 1.30
Interest 0.29 0.20 0.01 0.01 0.01 0.02 0.13 0.13
Depreciation 0.03 0.02 0.02 0.03 0.03 0.03 0.07 0.10
Profit before tax 0.00 0.10 0.04 0.07 0.01 0.06 0.26 -0.47
Tax % 30.00% 25.00% 28.57% 0.00% 16.67% 50.00% -25.53%
0.00 0.07 0.03 0.05 0.01 0.05 0.13 -0.36
EPS in Rs 0.00 4.67 0.25 0.24 0.05 0.24 0.62 -1.71
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 30%
3 Years: 50%
TTM: -37%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -377%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -13%
1 Year: -16%
Return on Equity
10 Years: %
5 Years: -1%
3 Years: -1%
Last Year: -9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.15 0.15 1.20 2.10 2.10 2.10 2.10 2.10
Reserves 0.45 0.52 0.10 2.00 2.01 2.06 2.19 1.83
2.52 1.08 0.31 0.05 0.41 0.84 1.61 1.11
5.43 1.83 0.65 0.48 0.50 4.50 7.11 12.28
Total Liabilities 8.55 3.58 2.26 4.63 5.02 9.50 13.01 17.32
0.10 0.08 0.16 0.17 0.15 0.24 0.46 0.37
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.05 0.05 0.05
8.45 3.50 2.10 4.46 4.87 9.21 12.50 16.90
Total Assets 8.55 3.58 2.26 4.63 5.02 9.50 13.01 17.32

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.18 2.44 -0.45 -1.90 -0.68 -2.99 -0.12 0.59
-0.01 0.00 -0.10 -0.05 -0.01 -0.18 -0.29 -0.01
-0.18 -2.37 0.45 2.47 0.34 0.43 0.61 -0.63
Net Cash Flow 0.00 0.07 -0.10 0.52 -0.35 -2.75 0.20 -0.05
Free Cash Flow 0.17 2.44 -0.54 -1.95 -0.69 -3.11 -0.41 0.58
CFO/OP 56% 772% -600% -1,900% -2,233% -2,700% 6% -38%

Ratios

Standalone / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 338.55 113.09 158.64 125.44 274.84 377.75 174.70 405.27
Inventory Days 988.71 15.36 62.61 174.83 147.24 88.59 26.56 28.69
Days Payable 1,024.81 77.34 63.94 34.76 45.78 294.40 143.21 374.56
Cash Conversion Cycle 302.45 51.11 157.31 265.51 376.29 171.94 58.05 59.40
Working Capital Days 19.84 51.93 165.80 292.70 444.30 282.40 103.16 137.43
ROCE % 12.32% 2.98% 2.78% 0.46% 1.68% 7.16% -6.22%

Insights

In beta
Mar 2019 Mar 2020 Jun 2021 Mar 2023 Mar 2024 Mar 2025
Exports as % of total revenue
%

Log in to view insights

Please log in to see hidden values.

Login
Number of permanent employees
count
Capacity utilization (in-house products)
%
In-house manufacturing capacity (Protein/Malt Powder)
tonnes per annum
Number of active products/SKUs
count
Number of domestic distributors
count
Number of export distributors/agents
count
Top 5 customer concentration
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
56.82% 56.82% 56.82% 56.82% 56.82% 56.82% 56.82% 56.82% 56.82%
43.18% 43.19% 43.18% 43.18% 43.18% 43.18% 43.18% 43.18% 43.18%
No. of Shareholders 195168160151138138137129141

Documents